Difference between revisions of "Example orders for Docetaxel & Carboplatin in prostate cancer"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - " - 30 minutes prior" to "; 30 minutes prior") |
Warner-admin (talk | contribs) m (Text replacement - "====Supportive medications" to "====Supportive therapy") |
||
Line 14: | Line 14: | ||
'''21-day cycles''' | '''21-day cycles''' | ||
− | ====Supportive | + | ====Supportive therapy==== |
*[[Dexamethasone (Decadron)]] 8 mg PO given twice, the evening before and morning of chemotherapy | *[[Dexamethasone (Decadron)]] 8 mg PO given twice, the evening before and morning of chemotherapy | ||
*[[Dexamethasone (Decadron)]] 12 mg PO once; 30 minutes prior to chemotherapy | *[[Dexamethasone (Decadron)]] 12 mg PO once; 30 minutes prior to chemotherapy |
Revision as of 14:39, 6 October 2022
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature.
Docetaxel & Carboplatin
Published regimens and references can be found on the prostate cancer page.
Example order set #1
- Docetaxel (Taxotere) 60 mg/m2 IV over 60 minutes once on day 1; use non-DEHP (paclitaxel) tubing
- Carboplatin (Paraplatin) AUC 4 IV once over 30 to 60 minutes once on day 1
21-day cycles
Supportive therapy
- Dexamethasone (Decadron) 8 mg PO given twice, the evening before and morning of chemotherapy
- Dexamethasone (Decadron) 12 mg PO once; 30 minutes prior to chemotherapy
- Ondansetron (Zofran) 8 mg PO once; 30 minutes prior to chemotherapy
Hydration:
- Normal saline IV continuous infusion at 5 mL/H
- Normal saline 25 to 50 mL IV prn flush before and after chemotherapy
Nursing:
- Patients without central lines: insert peripheral IV before therapy. Flush peripheral IV with 10 mL 0.9% normal saline after each day's dose of chemotherapy. Remove peripheral IV when therapy is complete.
- Patients with central lines: access the central venous access device before therapy. Flush central line according to institutional guidelines after each day's dose of chemotherapy. Deaccess device when therapy is complete.